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LETTER TO THE EDITOR
Reply to the concerns raised by McKenna and Heaney about COSMIN
Dear Editor,
We would like to respond to the paper by McKenna and
Heaney1, in which they express their concerns with regard to
the COSMIN methodology2. We appreciate the attention to
our work, and more in general, to the quality of outcome
measurement instruments. We very much agree on many of
the issues raised. Assessing the quality of measurement
instruments is a challenging task which requires knowledge
of the construct to be measured, the patient population that
is being measured, and the methods of quality assessment
of measurement instruments. Therefore, the COSMIN guide-
lines strongly recommend to conduct systematic reviews on
outcome measurement instruments by a multidisciplinary
team consisting of experts on all these aspects3. High quality
systematic reviews can provide a comprehensive overview of
the measurement properties of existing PROMs and supports
evidence-based recommendations in the selection of the
most suitable PROM available2. As these reviews are chal-
lenging, complex and time-consuming to conduct, we devel-
oped a systematic methodology to allow systematic and
transparent processing of all evidence. In addition to the
COSMIN methodology for conducting systematic reviews on
PROMs2, including the COSMIN Risk of Bias checklist for
PROMs4,5, we developed the COSMIN Risk of Bias tool for
assessing reliability and measurement error for any type of
instrument6, the COSMIN Study Design checklist7 and the
COSMIN reporting guideline for studies on measurement
properties of PROMs8. Note, that each checklist (often
accompanied by a peer-reviewed publication, and a user
manual) has its own specific purpose.
McKenna and Heaney point to the importance of using
conceptual models when developing measurement instru-
ments and evaluating their measurement properties, and
suggest that the COSMIN methodology doesn’t pay enough
attention to defining the construct by grounding it in a the-
ory1. However, in the COSMIN Risk of Bias checklist, the
standards 1 and 2 in Box 1 PROM development, refer to the
clarity of the construct, and the use of a conceptual model,
respectively5. Moreover, in the COSMIN methodology defin-
ing the construct is the starting point of a systematic review.
Authors of reviews should clearly define the scope of the
review, in terms of the construct, the target population, and
the context of use9. This scope is the reference point for
assessing content validity9 and for formulating hypotheses
for assessing construct validity or responsiveness3. It is up to
the reviewers to decide whether they consider a construct to
be clearly described, or whether the origin of the construct
is clear9. However, this is difficult to determine. We agree to
McKenna and Heaney that we reviewers should generally be
more strict in this judgement.
A second point these authors raised refers to the use of
unidimensional scales, suggesting that within the COSMIN
methodology the importance of this is ignored1. However,
COSMIN also addresses that evidence is required on the uni-
dimensionality of (sub)scales based on a reflective model. In
the COSMIN methodology3,9 each subscale of a multi-dimen-
sional PROM should be considered as a separate measure-
ment instrument. Moreover, internal consistency should be
assessed only for unidimensional (sub)scales (Standard 1 Box
4 Internal Consistency), and the assessment of internal con-
sistency (by means of a Cronbach alpha) can only be suffi-
cient when there is proof that the scale is unidimensional
(criteria for sufficient internal consistency, see Table 1 of
Prinsen et al.2).
McKenna and Heaney clearly explain the advantages of
developing PROMs using Rasch or IRT analyses1. Indeed, the
CLIQ PROM10 developed by McKenna and colleagues, was
developed based on qualitative studies, in combination with
Rasch analyses. We agree that the combination of these two
methods is the best method for developing instruments. In
the COSMIN methodology, we therefore first consider con-
tent validity and explicitly label that as the most important
measurement property2. Furthermore, when assessing the
content validity, the development of the PROM is explicitly
taken into account5. Standards to assess the quality of the
development of a PROM or a study on content validity refer
to qualitative methods. The next step is to assess structural
validity2. Therefore, we developed standards and criteria for
studies using factor analyses methods, and IRT or Rasch
methods. Nevertheless, when evaluating an instrument, we
think IRT or Rasch methods and CTT methods complement
each other. Both provide different kinds of information on
the quality of an instrument. Moreover, the goal of a system-
atic review of measurement instruments is often to select
the most suitable instrument that is available for use. A sys-
tematic review will obviously be restricted to existing instru-
ments and studies, which are still often based on CTT.
However, in recent years there is an increase in studies using
IRT and Rasch methods. We acknowledge that the COSMIN
standards and criteria for these methods should be devel-
oped further. We also agree with McKenna and Heaney’s call
to develop instruments based on IRT or Rasch to achieve
scales with interval or ratio level data.
Next, McKenna and Heaney suggest that the COSMIN
checklist is based on opinion and not on evidence. The
COSMIN checklist was developed using Delphi studies5,6,11.
The proposals which were proposed to the experts were
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based on existing methodological literature. We invited
measurement experts to contribute to the development, and
asked them after each proposal to give their arguments and/
or provide literature suggestions for their opinion. These
arguments and methodological literature were definitively
considered when developing the standards and criteria. So,
while we agree that opinions were indeed the foundation of
the COSMIN methodology, we would like to emphasize that
these were opinions of experts who weighted and consid-
ered the arguments given for these opinions until a consen-
sus was reached.
A legitimate concern McKenna and Heaney raise is the
difference in conclusions drawn by different authors of sys-
tematic reviews using the COSMIN methodology1. The
question is whether this is due to the COSMIN method-
ology or to the expertise and use of COSMIN by these
authors. The COSMIN Risk of Bias checklist is not a cook-
book. Expertise is required and subjective judgement is
sometimes needed. Again, we point to the requirement of
having a review team with broad expertise, on both the
construct and patient population, but also on the method-
ology of the type of studies that are included, including
both CTT and IRT or Rasch based studies. Furthermore, we
facilitate users as much as we can by teaching courses of
clinimetrics12,13, and we are currently developing an online
course for conducting systematic reviews using the
COSMIN methodology. To further increase the quality of
systematic reviews of measurement instruments, we recom-
mend users of the COSMIN methodology to be transparent
in the methods used, including publishing the search strat-
egy that they used to find studies. We subsequently rec-
ommend to publish all results found in the included
studies (per measurement property per measurement
instrument) in extensive tables, for which we provided
examples (see Appendix 7 of the user manual3). This will
contribute to the transparency of the conclusions drawn,
and allows end users of the review to formulate their own
conclusions.
In addition to these important points raised by McKenna
and Heaney, we would like to clarify a misunderstanding
they seem to have about the COSMIN methodology. The
final ratings for the COSMIN Risk of Bias checklist are a
worst-score count rating per study per measurement prop-
erty14. We did not state that a PROM should have passed
75% of the checklist, as McKenna and Heaney wrongly
inferred1. What we recommend to do, after making this over-
view of all available evidence, is to categorize the instru-
ments, into (A) PROMs that have potential to be
recommended as the most suitable PROM for the construct
and population of interest; (B) PROMs that may have the
potential to be recommended, but further validation studies
are needed; and (C) PROMs that should not be recom-
mended (because of high quality evidence for insufficient
measurement properties)2.
Assessing the quality of PROMs and other measurement
instruments is complex. COSMIN aims to develop a method-
ology and practical tools to improve the quality of outcome
measurement instruments used in research and clinical prac-
tice. We welcome suggestions to further improve the
COSMIN materials to contribute to that goal and we invite
others to join us in the effort.
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